NISS predicts postinjury multiple organ failure better than the ISS

Journal of Trauma - Injury, Infection and Critical Care

Volumn 48, Issue 4, 2000, Pages 624-628

  Balogh, Zsolt ^a   Offner, Patrick J ^a   Moore, Ernest E ^a   Biffl, Walter L ^a  

^a DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; COMPARATIVE STUDY; CONFERENCE PAPER; HUMAN; INJURY SCALE; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE ORGAN FAILURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033997247     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/00005373-200004000-00007     Document Type: Conference Paper

References (32)

1. Waydhas C Nast-Kolb D, Jochum M, et al. Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg. 1992;127:460-467.
2. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am. 1995;75:257-277.
3. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg. 1992;216:117-134.
4. Baue AE. The horror autotoxicus and multiple-organ failure. Arch Surg. 1992;127:1451-1462.
5. Roumen RM, Redl H, Schlag G, et al. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med. 1995;23:474-480.
6. Donnelly TJ, Meade P, Jagels M, et al. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med. 1994;22:768-776.
7. Botha AJ, Moore FA, Moore EE, et al. Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J Trauma. 1995;39:411-417.
8. Partrick DA, Moore FA, Moore EE, Barnett CC Jr, Silliman CC. Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horiz. 1996; 4:194-210.
9. Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock. 1998;10:79-89.
10. Fisher CJ Jr, Opal SM, Dhainaut JF, et al. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med. 1993;21:318-327.
11. Fisher CJ Jr, Slotman GJ, Opal SM, et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open- label, placebo-controlled multicenter trial. The IL-1RA Sepsis Syndrome Study Group. Crit Care Med. 1994;22:12-21.
12. Fisher CJ Jr, Zheng Y. Potential strategies for inflammatory mediator manipulation: retrospect and prospect. World J Surg. 1996;20:447-453.
13. Guirao X, Lowry SF. Biologic control of injury and inflammation: much more than too little or too late. World J Surg. 1996;20:437-446.
14. Bone RC, Balk RA, Fein AM, et al. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized controlled trial. The E5 Sepsis Study Group. Cnt Care Med. 1995;23:994-1006.
15. Dofferhoff AS, Bom VJ, de Vries-Hospers HG, et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med. 1992; 20:185-192.
16. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg. 1996;20:454-459.
17. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101:1644-1655.
18. Sauaia A, Moore FA, Moore EE, et al. Early predictors of postinjury multiple organ failure. Arch Surg. 1994;129:39-45.
19. Sauaia A, Moore FA, Moore EE, Lezotte DC. Early risk factors for postinjury multiple organ failure. World J Surg. 1996;20:392-400.
20. Sauaia A, Moore FA, Moore EE, et al. Multiple organ failure can be predicted as early as 12 hours after injury. J Trauma. 1998;45:291-301.
21. Tran DD, Cuesta MA, van Leeuwen PA, Nauta JJ, Wesdorp RI. Risk factors for multiple organ system failure and death in critically injured patients. Surgery. 1993;114:21-30.
22. Henao FJ, Daes JE, Dennis RJ. Risk factors for multiorgan failure: a case-control study. J Trauma. 1991;31: 74-80.
23. Copes WS, Champion HR, Sacco WJ, et al. The Injury Severity Score revisited. J Trauma. 1988;28:69-77.
24. Osler T. Injury severity scoring: perspectives in development and future directions. Am J Surg. 1993;165:43S-51S.
25. Copes WS, Champion HR, Sacco WJ, et al. Progress in characterizing anatomic injury. J Trauma. 1990;30: 1200-1207.
26. Sacco WJ, Jameson JW, Copes WS, et al. Progress toward a new injury severity characterization: severity profiles. Comput Biol Med. 1988;18:419-429.
27. Champion HR, Copes WS, Sacco WJ, et al. A new characterization of injury severity. J Trauma. 1990;30:539-545
28. Champion HR, Copes WS, Sacco WJ, et al. Improved predictions from a severity characterization of trauma (ASCOT) over Trauma and Injury Severity Score (TRISS): results of an independent evaluation. J Trauma. 1996;40:42-48.
29. Markle J, Cayten CG, Byrne DW, Moy F, Murphy JG. Comparison between TRISS and ASCOT methods in controlling for injury severity. J Trauma. 1992;33:326-332.
30. Osler T, Baker SP, Long W. A modification of the Injury Severity Score that both improves accuracy and simplifies scoring. J Trauma. 1997;43:922-925.
31. Baker SP, O'Neill B, Haddon W Jr, Long WB. The Injury Severity Score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14:187-196.
32. Brenneman FD, Boulanger BR, McLellan BA, Redelmeier DA. Measuring injury severity: time for a change? J Trauma. 1998;44:580-582.